Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation

Open access

Abstract

Extracellular vesicles can cross the blood–brain barrier (BBB), but little is known about passage. Here, we used multiple-time regression analysis to examine the ability of 10 exosome populations derived from mouse, human, cancerous, and non-cancerous cell lines to cross the BBB. All crossed the BBB, but rates varied over 10-fold. Lipopolysaccharide (LPS), an activator of the innate immune system, enhanced uptake independently of BBB disruption for six exosomes and decreased uptake for one. Wheatgerm agglutinin (WGA) modulated transport of five exosome populations, suggesting passage by adsorptive transcytosis. Mannose 6-phosphate inhibited uptake of J774A.1, demonstrating that its BBB transporter is the mannose 6-phosphate receptor. Uptake rates, patterns, and effects of LPS or WGA were not predicted by exosome source (mouse vs. human) or cancer status of the cell lines. The cell surface proteins CD46, AVβ6, AVβ3, and ICAM-1 were variably expressed but not predictive of transport rate nor responses to LPS or WGA. A brain-to-blood efflux mechanism variably affected CNS retention and explains how CNS-derived exosomes enter blood. In summary, all exosomes tested here readily crossed the BBB, but at varying rates and by a variety of vesicular-mediated mechanisms involving specific transporters, adsorptive transcytosis, and a brain-to-blood efflux system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21124407

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Exosome characterization: (A) Exosomes were isolated from supernatants of Kasumi-1, a human leukemia cell line using mini-SEC as described in Materials and Methods. Exosomes in Fraction #4 were harvested and characterized by tunable resistive pulse sensing (TRPS) to determine their diameters and concentrations (left); by Western blots to show the presence of exosome markers and absence of cytoplasmic proteins (middle); and by TEM to illustrate vesicular morphology and the size range (right). (B) The TEM images, size distribution profiles and Western blot profiles of Mel526 exosomes (left) and exosomes produced by human T cells (middle). (a) The size distribution profile of circulating exosomes in CD-1 mouse plasma; (b) comparisons of total exosomal protein levels of circulating exosomes in the plasma of CD-1 mice and of normal human donors. The data are means ± SD from 3 independent measurements.
Figure 1 Exosome characterization: (A) Exosomes were isolated from supernatants of Kasumi-1, a human leukemia cell line using mini-SEC as described in Materials and Methods. Exosomes in Fraction #4 were harvested and characterized by tunable resistive pulse sensing (TRPS) to determine their diameters and concentrations (left); by Western blots to show the presence of exosome markers and absence of cytoplasmic proteins (middle); and by TEM to illustrate vesicular morphology and the size range (right). (B) The TEM images, size distribution profiles and Western blot profiles of Mel526 exosomes (left) and exosomes produced by human T cells (middle). (a) The size distribution profile of circulating exosomes in CD-1 mouse plasma; (b) comparisons of total exosomal protein levels of circulating exosomes in the plasma of CD-1 mice and of normal human donors. The data are means ± SD from 3 independent measurements.CC BY · PubMed Central
Figure 2 On-bead flow cytometry of exosome populations isolated from supernatants of 4 different cell lines, captured on streptavidin beads coated with biotinylated anti-CD63 mAbs and stained with the labeled detection Abs specific for CD46, αVβ6, αVβ3 and ICAM1 as described in Methods. Data are relative fluorescence intensity (RFI) values calculated as mean fluorescence intensity (MFI) of an experimental sample/MFI of an isotype control Ab. [White peaks = experimental samples; hatched peaks = isotope controls]. Note that exosomes produced by non-malignant cells (HaCaT and primary T cells) appear to differ from exosomes produced by malignant cells by the absence of αVβ3 and lower expression levels of αVβ6. Representative results are from 1 to 3 detection experiments performed with each exosome population.
Figure 2 On-bead flow cytometry of exosome populations isolated from supernatants of 4 different cell lines, captured on streptavidin beads coated with biotinylated anti-CD63 mAbs and stained with the labeled detection Abs specific for CD46, αVβ6, αVβ3 and ICAM1 as described in Methods. Data are relative fluorescence intensity (RFI) values calculated as mean fluorescence intensity (MFI) of an experimental sample/MFI of an isotype control Ab. [White peaks = experimental samples; hatched peaks = isotope controls]. Note that exosomes produced by non-malignant cells (HaCaT and primary T cells) appear to differ from exosomes produced by malignant cells by the absence of αVβ3 and lower expression levels of αVβ6. Representative results are from 1 to 3 detection experiments performed with each exosome population.CC BY · PubMed Central
Figure 3 Clearance of exosomes from blood demonstrated two major patterns: phase decay, as exemplified by SCCVII (mouse tumor) exosomes and no change with time as exemplified by MEL526 (human melanoma) exosomes.
Figure 3 Clearance of exosomes from blood demonstrated two major patterns: phase decay, as exemplified by SCCVII (mouse tumor) exosomes and no change with time as exemplified by MEL526 (human melanoma) exosomes.CC BY · PubMed Central
Figure 4 Examples of patterns for BBB passage and brain accumulation. Brain/serum ratios have been corrected for vascular space by subtracting albumin brain/serum ratios. Left upper panel illustrates continuous linear uptake of SCC-90 exosomes. Right upper and left lower panels illustrate a plateau pattern as seen with primary T cell-derived and SCCVII-derived exosomes. Only the HaCaT exosomes (right lower panel) did not show an increase in the brain/serum ratio with time. The closed circles represent data points describing the linear portion of the curve; the open circles represent data points that departed from linearity. See Table 3 for statistics.
Figure 4 Examples of patterns for BBB passage and brain accumulation. Brain/serum ratios have been corrected for vascular space by subtracting albumin brain/serum ratios. Left upper panel illustrates continuous linear uptake of SCC-90 exosomes. Right upper and left lower panels illustrate a plateau pattern as seen with primary T cell-derived and SCCVII-derived exosomes. Only the HaCaT exosomes (right lower panel) did not show an increase in the brain/serum ratio with time. The closed circles represent data points describing the linear portion of the curve; the open circles represent data points that departed from linearity. See Table 3 for statistics.CC BY · PubMed Central
Figure 5 Variation in the uptake of different exosome populations by brain regions. Four exosome populations showed a significantly greater uptake by the olfactory bulb (OB) than by whole brain (WBr), cortex (Cx), or cerebellum (Cb). * p < 0.05, ** p < 0.01, **** p < 0.0001.
Figure 5 Variation in the uptake of different exosome populations by brain regions. Four exosome populations showed a significantly greater uptake by the olfactory bulb (OB) than by whole brain (WBr), cortex (Cx), or cerebellum (Cb). * p < 0.05, ** p < 0.01, **** p < 0.0001.CC BY · PubMed Central
Figure 6 Effects of LPS on exosome uptake by various brain regions. Upper left: uptake of primary T cell-derived exosomes by whole brain (WBr) and cortex (Cx), but not by OB (olfactory bulb) or cerebellum (Cb), was increased by LPS. Upper right: for MDA-MB-231-derived exosomes; LPS increased uptake by the OB and the WBr. Lower left: for PCI-30-derived exosomes, LPS increased uptake into all the assessed regions. Lower right: for SCCVII-derived exosomes, LPS decreased uptake by the OB and the CX. * p < 0.05, *** p < 0.001.
Figure 6 Effects of LPS on exosome uptake by various brain regions. Upper left: uptake of primary T cell-derived exosomes by whole brain (WBr) and cortex (Cx), but not by OB (olfactory bulb) or cerebellum (Cb), was increased by LPS. Upper right: for MDA-MB-231-derived exosomes; LPS increased uptake by the OB and the WBr. Lower left: for PCI-30-derived exosomes, LPS increased uptake into all the assessed regions. Lower right: for SCCVII-derived exosomes, LPS decreased uptake by the OB and the CX. * p < 0.05, *** p < 0.001.CC BY · PubMed Central
Figure 7 Effects of WGA and M6P on exosome uptake by whole brain. Shown are data for 5/10 tested exosome populations in which WGA significantly enhanced uptake. M6P inhibited uptake of 1/10 exosome populations tested (see J774A.1). Neither WGA nor M6P had an effect on primary T cell-derived exosomes, ** p < 0.01, **** p < 0.001.
Figure 7 Effects of WGA and M6P on exosome uptake by whole brain. Shown are data for 5/10 tested exosome populations in which WGA significantly enhanced uptake. M6P inhibited uptake of 1/10 exosome populations tested (see J774A.1). Neither WGA nor M6P had an effect on primary T cell-derived exosomes, ** p < 0.01, **** p < 0.001.CC BY · PubMed Central
Figure 8 Brain-to-blood efflux of HaCaT-derived exosomes after ICV administration. Upper panel: open circles show that exosome clearance from brain had a half-life of 7.85 min; open circles show that exosomes reach an equilibrium after about 10 min. Lower panel: Appearance of HaCaT exosomes in blood was stable at a mean of 3.9%.
Figure 8 Brain-to-blood efflux of HaCaT-derived exosomes after ICV administration. Upper panel: open circles show that exosome clearance from brain had a half-life of 7.85 min; open circles show that exosomes reach an equilibrium after about 10 min. Lower panel: Appearance of HaCaT exosomes in blood was stable at a mean of 3.9%.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Nicolini, M., and Zatta, P.F. (1994). Glycoconjugates and anionic sites in the blood-brain barrier. Glycobiology and the Brain, Pergamon Press.

Cited by

See all 569

Metadata

Authors
Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L.
Affiliations
  • University of Washington (US)
  • University of Pittsburgh (US)
Corresponding author
Banks, William A.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-06-21
Volume
21
Issue
12
Pages
4407
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3036596408
Cited by
561
References
57
Citations by year
2026: 99 · 2025: 102 · 2024: 132 · 2023: 90 · 2022: 81 · 2021: 54 · 2020: 2
FWCI
18.72
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Institutes of Health (1RO1 AG046619)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
extracellular vesicles, exosomes, blood-brain barrier, BBB crossing, brain pharmacokinetics, lipopolysaccharide, inflammation, mannose 6-phosphate receptor, CD46, integrins, ICAM-1, vesicular transporters
MeSH terms
Animals, Biological Transport, Blood-Brain Barrier, Cell Line, Humans, Inflammation, Male, Cell Line, Tumor, Mice, Exosomes, Transcytosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. https://app.cochat.ai/papers/10.3390/ijms21124407
The paper
Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020). Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21124407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.